Floatz logo

Rizatriptan

Chronic Post-traumatic Headache

Henry M. Jackson Foundation for the Advancement of Military MedicineSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Chronic Post-traumatic Headache cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Rizatriptan is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine without auraDormant
B
Indicative ·
62 / 100
View asset →
Migrainous VertigoDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →